BTIG Research reiterated their buy rating on shares of Verastem (NASDAQ:VSTM – Free Report) in a research report sent to investors on Friday,Benzinga reports. BTIG Research currently has a $18.00 price target on the biopharmaceutical company’s stock. Other analysts also recently issued reports about the stock. Weiss Ratings upgraded shares of Verastem from a “sell […]

BTIG Research reiterated their buy rating on shares of SailPoint (NASDAQ:SAIL – Free Report) in a report released on Wednesday morning,Benzinga reports. The brokerage currently has a $21.00 price objective on the stock. A number of other equities research analysts have also recently commented on SAIL. Jefferies Financial Group reaffirmed a “buy” rating and issued […]

BTIG Research reissued their buy rating on shares of Neuronetics (NASDAQ:STIM – Free Report) in a report issued on Wednesday morning,Benzinga reports. The brokerage currently has a $6.00 target price on the stock. Several other brokerages have also weighed in on STIM. Citigroup reissued a “market outperform” rating on shares of Neuronetics in a report […]

Macy’s (NYSE:M – Get Free Report)‘s stock had its “neutral” rating reaffirmed by stock analysts at BTIG Research in a research note issued on Friday, Benzinga reports. A number of other research firms also recently commented on M. Weiss Ratings upgraded Macy’s from a “hold (c+)” rating to a “buy (b-)” rating in a report […]

BTIG Research reaffirmed their buy rating on shares of BioAge Labs (NASDAQ:BIOA – Free Report) in a research note released on Tuesday morning,Benzinga reports. The brokerage currently has a $40.00 price objective on the stock. A number of other equities analysts also recently issued reports on the stock. Jefferies Financial Group set a $21.00 price […]

AeroVironment (NASDAQ:AVAV – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at BTIG Research in a research note issued to investors on Thursday, Benzinga reports. They presently have a $205.00 price target on the aerospace company’s stock. BTIG Research’s price target would indicate a potential upside of 45.60% from the company’s […]

BTIG Research reaffirmed their neutral rating on shares of Asana (NYSE:ASAN – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. A number of other equities research analysts also recently weighed in on the stock. UBS Group reaffirmed a “neutral” rating and set a $8.00 price objective on shares of Asana […]

BTIG Research reissued their buy rating on shares of Guardant Health (NASDAQ:GH – Free Report) in a research note released on Wednesday morning,Benzinga reports. BTIG Research currently has a $195.00 target price on the stock. A number of other equities analysts have also commented on the stock. Evercore reissued an “outperform” rating and issued a […]

BTIG Research restated their buy rating on shares of Kestra Medical Technologies (NASDAQ:KMTS – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $32.00 price target on the stock. A number of other research analysts also recently issued reports on KMTS. Oppenheimer initiated coverage on Kestra Medical Technologies […]